Early signs of shingles nerve pain
Part of Blood & lymphatic, Brain & nervous system, Pain clinical trials.
This study looks for early signs in the body that might predict how shingles pain develops into long-term nerve pain. It may help find people at higher risk and guide better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are exactly 50 years old
- You have post-herpetic neuralgia (pain after shingles) with a duration of less than 2 months or more than 3 months
- You do not have any other chronic pain conditions
- You do not have digestive disorders like irritable bowel syndrome or inflammatory bowel disease
- You have not taken antibiotics, acid reducers, or drugs that affect gut bacteria in the past month
- You do not have a weakened immune system, autoimmune disease, mental illness, or heavy tobacco/alcohol use
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three injected treatments—tiny cell particles, platelet-rich plasma, and steroids—directly into the skin to reduce long-lasting nerve pain that follows shingles. If you've had persistent shingles pain for at least 3 months, this study may help ease your discomfort.
This study tests whether electroacupuncture (a type of acupuncture using mild electric pulses) can reduce nerve pain after shingles. It also looks for biomarkers to see how the treatment works.
This study tests whether warm acupuncture can help relieve persistent nerve pain after shingles (postherpetic neuralgia). It may offer a non-drug option for people whose pain has not gone away after the rash heals.
This trial tests a new tablet called HL-1186 for treating post-herpetic neuralgia (long-lasting pain after shingles). It compares the new drug to pregabalin, a standard treatment, to see if it's safer and more effective.
This trial tests a pain-relieving brain stimulation treatment for people with long-lasting pain after shingles (called postherpetic neuralgia). It compares the real treatment to a sham (inactive) procedure to see if it truly reduces pain.
This trial tests a two-step procedure for treating nerve pain after shingles (called postherpetic neuralgia). First, a special type of radiofrequency treatment is applied to block the pain signals. Then, a long-lasting numbing medicine is injected under the skin to help keep the pain away. It is for people aged 40 to 85 who have not gotten enough relief from standard medicines.
Hear when a new Postherpetic Neuralgia ( PHN ) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.